KMID : 0614720150580050420
|
|
Journal of Korean Medical Association 2015 Volume.58 No. 5 p.420 ~ p.432
|
|
The Korean guideline for colorectal cancer screening
|
|
Sohn Dae-Kyung
Kim Min-Ju Park Youn-Hee Suh Min-A Shin Ae-Sun Lee Hee-Young Im Jong-Pil Cho Hyun-Min Hong Sung-Pil Kim Baek-Hui Kim Yong-Soo Kim Jeong-Wook Kim Hyun-Soo Nam Chung-Mo Park Dong-Il Um Jun-Won Oh Soon-Nam Lim Hwan-Sub Chang Hee-Jin Hahm Sang-Keun Chung Ji-Hye Kim Soo-Young Kim Yeol Lee Won-Chul Jeong Seong-Hae
|
|
Abstract
|
|
|
Colorectal cancer is the third most common cancer in Korea; it is the second most common cancer in men and the third most common in women. The incidence rate in Korea has continuously increased since 1999 when the National Cancer Registry statistics began. Currently; there are several screening modalities; that have been recommended by expert societies, including fecal occult blood test, colonoscopy, computed tomographic colonography The annual fecal immunochemical test (FIT) has been used in adults aged 50 and older as part of the National Cancer Screening Program in Korea since 2004. Although several study results from regional or national colorectal cancer screening programs in other countries have been reported, the National Cancer Screening Program in Korea has not yet been evaluated with evidence-based methods. Herein report the consensus statements on the National Screening Guideline for colorectal cancer developed by a multi-society expert committee in Korea, as follows: 1) We recommend annual or biennial FIT for screening for colorectal cancer in asymptomatic adults, beginning at 45 years of age and continuing until 80 years (recommendation B). 2) There is no evidence for the risks or benefits of FIT in adults older than 80 years (recommendation I). 3) Selective use of colonoscopy for colorectal cancer screening is recommended, taking into consideration individual preference and the risk of colorectal cancer (recommendation C). 4) There is no evidence for the risks or benefits of double-contrast barium enema for colorectal cancer screening in asymptomatic adults (recommendation I). 5) There is no evidence for the risks or benefits of computed tomographic colonography for colorectal cancer screening in asymptomatic adults (recommendation I).
|
|
KEYWORD
|
|
Early detection of cancer, Colorectal neoplasms, Occult blood, Colonoscopy, Computed tomographic colonography
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|